drugset / Trial / NCT03666663

Sphenopalatine Ganglion Blocks RCT

NCT03666663 ↗

Phase 4 Completed 10 enrolled University of California, San Francisco
RandomizedParallel-groupQuadruple-blindTreatment

Summary

RCT of Sphenopalatine Ganglion (SPG) Blocks using anesthetics vs. placebo for migraine.

Timeline

Start
2019-02-01
Primary completion
2021-07-08
Completion
2021-07-08

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified — Intranasal
Subject Lidocaine Other / unclassified — Intranasal
Subject Ropivacaine Other / unclassified — Intranasal

Indications